biostudies-literatureUnknown11(3)Shen NRMD openhttps://www.ebi.ac.uk/biostudies/studies/S-EPMC12352177biostudies-literatureEfficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II studyPMC12352177Sips CGergely PWeinmann-Menke JDanekula RShen NSerra-Roma AFelten RShisha TRohr JWeiss MMalvar AfalseEfficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II study2025-01-01T00:00:00Z2025 Jan2026-05-29T15:08:36.994Z2026-04-08T05:11:55.94ZS-EPMC12352177